Efficacy and safety of erdafitinib in patients with advanced or metastatic cholangiocarcinoma and FGFR alterations: Pooled analysis of RAGNAR and LUC2001 studies Meeting Abstract
| Authors: | Pant, S.; Park, J. O.; Su, W. C.; Schuler, M. H.; Loriot, Y.; Iyer, G.; Doi, T.; Qin, S.; Tabernero, J.; Prenen, H.; Folprecht, G.; Winter, H.; Dal Molin, G. Z.; Sweiti, H.; Najmi, S.; Hammond, C.; Liao, H.; Thomas, S.; Triantos, S.; Feng, Y. H. |
| Abstract Title: | Efficacy and safety of erdafitinib in patients with advanced or metastatic cholangiocarcinoma and FGFR alterations: Pooled analysis of RAGNAR and LUC2001 studies |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401092 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.4121 |
| Notes: | Meeting Abstract: 4121 -- Source: Wos |
